{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:02:16Z","timestamp":1776092536536,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84914-y","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:44:36Z","timestamp":1741891476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of racemic anisodamine in combination with orthokeratology and defocus incorporated multiple segment spectacle lenses for myopia control in adolescents"],"prefix":"10.1038","volume":"15","author":[{"given":"Yi","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jing","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"1","key":"84914_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"PN Baird","year":"2020","unstructured":"Baird, P. N. et al. Myopia. Nat. Rev. Dis. Primers. 6(1), 99. https:\/\/doi.org\/10.1038\/s41572-020-00231-4 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"84914_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1001\/jamaophthalmol.2021.3303","volume":"139","author":"R Du","year":"2021","unstructured":"Du, R. et al. Continued increase of axial length and its risk factors in adults with high myopia. JAMA Ophthalmol. 139(10), 1096\u20131103. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.3303 (2021).","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"84914_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40101-024-00354-7","volume":"43","author":"S Biswas","year":"2024","unstructured":"Biswas, S., Kareh, E. & Qureshi, A. The influence of the environment and lifestyle on myopia. J. Physiol. Anthropol. 43(1), 7. https:\/\/doi.org\/10.1186\/s40101-024-00354-7 (2024).","journal-title":"J. Physiol. Anthropol."},{"key":"84914_CR4","doi-asserted-by":"publisher","first-page":"817882","DOI":"10.3389\/fpubh.2021.817882","volume":"9","author":"L Tao","year":"2021","unstructured":"Tao, L. et al. Correlation between increase of axial length and height growth in Chinese school-age children. Front. Public. Health. 9, 817882. https:\/\/doi.org\/10.3389\/fpubh.2021.817882 (2021).","journal-title":"Front. Public. Health"},{"issue":"5","key":"84914_CR5","doi-asserted-by":"publisher","first-page":"101427","DOI":"10.1016\/j.clae.2021.02.013","volume":"44","author":"LC Chang","year":"2021","unstructured":"Chang, L. C., Sun, C. C. & Liao, L. L. Compliance with orthokeratology care among parents of young children in Taiwan. Cont. Lens Anterior Eye. 44(5), 101427. https:\/\/doi.org\/10.1016\/j.clae.2021.02.013 (2021).","journal-title":"Cont. Lens Anterior Eye"},{"issue":"14","key":"84914_CR6","first-page":"2552","volume":"48","author":"HF Li","year":"2021","unstructured":"Li, H. F. & Mo, J. Myopia and risk factors among Chinese adolescents. Mod. Prev. Med. 48(14), 2552\u20132557 (2021).","journal-title":"Mod. Prev. Med."},{"issue":"3","key":"84914_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/ICL.0000000000000867","volume":"48","author":"T Hiraoka","year":"2022","unstructured":"Hiraoka, T. Myopia control with orthokeratology: A review. Eye Contact Lens. 48(3), 100\u2013104. https:\/\/doi.org\/10.1097\/ICL.0000000000000867 (2022).","journal-title":"Eye Contact Lens"},{"issue":"2","key":"84914_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/ijms.30118","volume":"16","author":"Q Zhu","year":"2019","unstructured":"Zhu, Q. et al. Retardation of myopia progression by multifocal soft contact lenses. Int. J. Med. Sci. 16(2), 198\u2013202. https:\/\/doi.org\/10.7150\/ijms.30118 (2019).","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"84914_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clae.2020.03.018","volume":"43","author":"MA Bullimore","year":"2020","unstructured":"Bullimore, M. A. & Johnson, L. A. Overnight orthokeratology. Cont. Lens Anterior Eye. 43(4), 322\u2013332. https:\/\/doi.org\/10.1016\/j.clae.2020.03.018 (2020).","journal-title":"Cont. Lens Anterior Eye"},{"key":"84914_CR10","unstructured":"Banerjee, S. & Horton, J. Lenses and spectacles to prevent myopia worsening in children. CADTH Health Technology Review."},{"issue":"5","key":"84914_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/OPX.0000000000000573","volume":"92","author":"DJ Gardner","year":"2015","unstructured":"Gardner, D. J., Walline, J. J. & Mutti, D. O. Choroidal thickness and peripheral myopic defocus during orthokeratology. Optometry Vis. Sci. Official Publication Am. Acad. Optometry. 92(5), 579\u2013588. https:\/\/doi.org\/10.1097\/OPX.0000000000000573 (2015).","journal-title":"Optometry Vis. Sci. Official Publication Am. Acad. Optometry"},{"issue":"1","key":"84914_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40662-023-00356-z","volume":"10","author":"RKM Chun","year":"2023","unstructured":"Chun, R. K. M. et al. Defocus incorporated multiple segments (DIMS) spectacle lenses increase the choroidal thickness: A two-year randomized clinical trial. Eye Vis. (Lond). 10(1), 39. https:\/\/doi.org\/10.1186\/s40662-023-00356-z (2023).","journal-title":"Eye Vis. (Lond)"},{"issue":"7","key":"84914_CR13","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.7150\/ijms.93643","volume":"21","author":"CY Lee","year":"2024","unstructured":"Lee, C. Y. et al. Comparison of myopic control between orthokeratology contact lenses and defocus incorporated multiple segments spectacle lenses. Int. J. Med. Sci. 21(7), 1329\u20131336. https:\/\/doi.org\/10.7150\/ijms.93643 (2024).","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"84914_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JCYF Frcsedin","year":"2019","unstructured":"Frcsedin, J. C. Y. F. et al. Low-concentration atropine for myopia progression (LAMP) study: A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% Atropine Eye drops in Myopia Control\u2014ScienceDirect. Ophthalmology 126(1), 113\u2013124 (2019).","journal-title":"Ophthalmology"},{"issue":"2","key":"84914_CR15","doi-asserted-by":"publisher","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci, P. et al. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS One. 18(2), e0281816. https:\/\/doi.org\/10.1371\/journal.pone.0281816 (2023).","journal-title":"PLoS One"},{"issue":"6","key":"84914_CR16","first-page":"42","volume":"5","author":"B Wang","year":"2022","unstructured":"Wang, B. et al. Anisodamine affects the pigmentation, mineral density, craniofacial area, and eye development in zebrafish embryos. J. Appl. Toxicol. 5(6), 42 (2022).","journal-title":"J. Appl. Toxicol."},{"issue":"7","key":"84914_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/OPX.0000000000000867","volume":"93","author":"NY Koomson","year":"2016","unstructured":"Koomson, N. Y. et al. Relationship between reduced accommodative lag and myopia progression. Optom. Vis. Sci. 93(7), 683\u2013691. https:\/\/doi.org\/10.1097\/OPX.0000000000000867 (2016).","journal-title":"Optom. Vis. Sci."},{"issue":"5","key":"84914_CR18","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1167\/iovs.16-20240","volume":"58","author":"HE Bowrey","year":"2017","unstructured":"Bowrey, H. E. et al. The effect of spectacle lenses containing peripheral defocus on refractive error and horizontal eye shape in the guinea pig. Invest. Ophthalmol. Vis. Sci. 58(5), 2705\u20132714. https:\/\/doi.org\/10.1167\/iovs.16-20240 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"84914_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.survophthal.2021.06.005","volume":"67","author":"A Medina","year":"2022","unstructured":"Medina, A. The cause of myopia development and progression: Theory, evidence, and treatment. Surv. Ophthalmol. 67(2), 488\u2013509. https:\/\/doi.org\/10.1016\/j.survophthal.2021.06.005 (2022).","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"84914_CR20","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.clae.2024.102122","volume":"47","author":"W Lu","year":"2024","unstructured":"Lu, W. et al. Different efficacy in myopia control: Comparison between orthokeratology and defocus-incorporated multiple segment lenses. Contact lens Anterior eye: J. Br. Contact Lens Association. 47(2), 102122. https:\/\/doi.org\/10.1016\/j.clae.2024.102122 (2024).","journal-title":"Contact lens Anterior eye: J. Br. Contact Lens Association"},{"key":"84914_CR21","doi-asserted-by":"crossref","unstructured":"Hiraoka, T. Myopia control with Orthokeratology: A review. Eye Contact lens (2021).","DOI":"10.1097\/ICL.0000000000000867"},{"issue":"1","key":"84914_CR22","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1038\/s41598-023-32700-7","volume":"13","author":"CSY Lam","year":"2023","unstructured":"Lam, C. S. Y. et al. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci. Rep. 13(1), 5475. https:\/\/doi.org\/10.1038\/s41598-023-32700-7 (2023).","journal-title":"Sci. Rep."},{"issue":"9","key":"84914_CR23","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","volume":"38","author":"T Tang","year":"2024","unstructured":"Tang, T. et al. Comparison of the long-term effects of atropine in combination with orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents. Eye 38(9), 1660\u20131667. https:\/\/doi.org\/10.1038\/s41433-024-02987-5 (2024).","journal-title":"Eye"},{"key":"84914_CR24","doi-asserted-by":"publisher","first-page":"115542","DOI":"10.1016\/j.biopha.2023.115542","volume":"167","author":"K Thomson","year":"2023","unstructured":"Thomson, K. et al. The role of the serotonergic system in atropine\u2019s anti-myopic effects. Biomed. Pharmacother. 167, 115542. https:\/\/doi.org\/10.1016\/j.biopha.2023.115542 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"84914_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia, A., Lu, Q. S. & Tan, D. Five-year clinical trial on atropine for the treatment of myopia 2: Myopia control with atropine 0.01% eyedrops. Ophthalmology 123(2), 391\u2013399. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.004 (2016).","journal-title":"Ophthalmology"},{"key":"84914_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fphar.2011.00023","volume":"2","author":"T Zhao","year":"2011","unstructured":"Zhao, T. et al. Beneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathway. Front. Pharmacol. 2, 23. https:\/\/doi.org\/10.3389\/fphar.2011.00023 (2011).","journal-title":"Front. Pharmacol."},{"issue":"11","key":"84914_CR27","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/bph.13486","volume":"173","author":"A Eisenkraft","year":"2016","unstructured":"Eisenkraft, A. & Falk, A. Possible role for anisodamine in organophosphate poisoning. Br. J. Pharmacol. 173(11), 1719\u20131727. https:\/\/doi.org\/10.1111\/bph.13486 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"84914_CR28","doi-asserted-by":"publisher","first-page":"114522","DOI":"10.1016\/j.biopha.2023.11452","volume":"161","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Update on the sources, pharmacokinetics, pharmacological action, and clinical application of anisodamine. Biomed. Pharmacother. 161, 114522. https:\/\/doi.org\/10.1016\/j.biopha.2023.11452 (2023).","journal-title":"Biomed. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84914-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:44:39Z","timestamp":1741891479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84914-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84914"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84914-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of the First Hospital Affiliated to Chongqing Higher School of Medicine and conducted in accordance with the Declaration of Helsinki and clinical practice guidelines. We briefed all participants in detail on the sample collection process, and informed consent to participate was obtained from the parents or legal guardians of any participant under the age of 16, all participants provided written informed consent following the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"8781"}}